Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gianluca Spitaleri, Roberto Biffi, Massimo Barberis, Caterina Fumagalli, Francesca Toffalorio, Chiara Catania, Cristina Noberasco, Chiara Lazzari, Filippo de Marinis & Tommaso De Pas. (2015) Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K). OncoTargets and Therapy 8, pages 1997-2003.
Read now
Read now
Kathinka E. Pitman, Espen Rusten, Alexandr Kristian & Eirik Malinen. (2015) Variability of dynamic 18F-FDG-PET data in breast cancer xenografts. Acta Oncologica 54:9, pages 1399-1407.
Read now
Read now
Alexandr Kristian, Mona Elisabeth Revheim, Hong Qu, Gunhild M. Mælandsmo, Olav Engebråten, Therese Seierstad & Eirik Malinen. (2013) Dynamic 18F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts. Acta Oncologica 52:7, pages 1566-1572.
Read now
Read now
Espen Rusten, Jan Rødal, Øyvind S. Bruland & Eirik Malinen. (2013) Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy. Acta Oncologica 52:7, pages 1378-1383.
Read now
Read now
Jan Rødal, Espen Rusten, Åste Søvik, Hege Kippenes Skogmo & Eirik Malinen. (2013) Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy. Acta Oncologica 52:7, pages 1293-1299.
Read now
Read now
Articles from other publishers (7)
Ekaterina Hanovich, Tim Asmis, Michael Ong & David Stewart. (2020) Rechallenge Strategy in Cancer Therapy. Oncology 98:10, pages 669-679.
Crossref
Crossref
Heidi M. Namløs, Kjetil Boye, Skyler J. Mishkin, Tale Barøy, Susanne Lorenz, Bodil Bjerkehagen, Eva W. Stratford, Else Munthe, Brian A. Kudlow, Ola Myklebost & Leonardo A. Meza-Zepeda. (2018) Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics 17:11, pages 2473-2480.
Crossref
Crossref
K Boye, J-M Berner, I Hompland, Ø S Bruland, S Stoldt, K Sundby Hall, B Bjerkehagen & T Hølmebakk. (2018) Genotype and risk of tumour rupture in gastrointestinal stromal tumour. British Journal of Surgery 105:2, pages e169-e175.
Crossref
Crossref
Thomas Van Looy, Yemarshet Kelemework Gebreyohannes, Agnieszka Wozniak, Jasmien Cornillie, Jasmien Wellens, Haifu Li, Ulla Vanleeuw, Giuseppe Floris, Maria Debiec-Rychter, Raf Sciot & Patrick Schöffski. (2014) Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors. Clinical Sarcoma Research 4:1.
Crossref
Crossref
Desmond Yip, John Zalcberg, Stephen Ackland, Andrew P Barbour, Jayesh Desai, Stephen Fox, Dusan Kotasek, Grant McArthur & B Mark Smithers. (2014) Controversies in the management of gastrointestinal stromal tumors. Asia-Pacific Journal of Clinical Oncology 10:3, pages 216-227.
Crossref
Crossref
Jason K Sicklick, Stephanie Y Leonard, Michele L Babicky, Chih-Min Tang, Evangeline S Mose, Randall P French, Dawn V Jaquish, Carl K Hoh, Michael Peterson, Richard Schwab & Andrew M Lowy. (2014) Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor. Journal of Translational Medicine 12:1, pages 41.
Crossref
Crossref
Elizabeth A. Kuczynski, Daniel J. Sargent, Axel Grothey & Robert S. Kerbel. (2013) Drug rechallenge and treatment beyond progression—implications for drug resistance. Nature Reviews Clinical Oncology 10:10, pages 571-587.
Crossref
Crossref